AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimefest M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Arkas Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimefest M 1mg/500mg Tablet

Diabetic patients using Glimefest M (1mg/500mg) tablets, a dual-action antidiabetic medication, manage type 2 diabetes mellitus effectively. This combination therapy regulates blood glucose levels in adults. Administer this medication with meals, consistently at the same time daily for optimal results. Dosage is personalized by your physician and adjusted based on blood sugar monitoring. Continuous use is crucial; abrupt cessation, without physician consultation, risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, including diet, exercise, and weight management as guided by your doctor. Commonly, Glimefest M can cause hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, dizziness, headache, and trembling, and know how to counteract them with a fast-acting sugar source (e.g., glucose tablets, fruit juice). Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating individuals require physician consultation. Regular blood glucose checks, along with blood tests to monitor blood cell counts and liver function, are recommended under your doctor’s supervision.

Uses of Glimefest M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimefest M 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimefest M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Glimefest M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimefest M 1mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimefest M 1mg/500mg tablets with food.

How Glimefest M 1mg/500mg Tablet works:

Glimefest M tablets (1mg glimepiride/500mg metformin) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts triply: it decreases hepatic glucose output, slows intestinal glucose uptake, and improves insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimefest M 1mg/500mg Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimefest M 1mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimefest M 1mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with abnormally low or high blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimefest M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimefest M 1mg/500mg tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimefest M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiate treatment with a low Glimefest M 1mg/500mg tablet dose; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimefest M 1mg/500mg Tablet :

Should you forget a Glimefest M 1mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimefest M 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimefest M 1mg/500mg Tablet

Retain this medication within its original, sealed container or packaging. Follow the storage directions printed on the container or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Glimefest M 1mg/500mg Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this is an uncommon but potentially dangerous side effect, particularly risky for individuals with kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms can encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms arise, discontinue Glimefest M 1mg/500mg Tablet intake and seek immediate medical attention.
Glimefest M 1mg/500mg tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances glycemic control when coupled with a healthy diet and physical activity. Glimepiride stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose output and improves cellular insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Glimefest M 1mg/500mg tablets may cause common side effects such as low blood sugar, taste changes, nausea, abdominal pain, diarrhea, and headache. Less frequent, but serious adverse reactions include lactic acidosis. Prolonged treatment might result in vitamin B12 deficiency.
Glimefest M 1mg/500mg tablets may induce Vitamin B12 deficiency with prolonged administration due to impaired Vitamin B12 absorption in the gastrointestinal tract. This deficiency, if left unaddressed, can lead to anemia, neurological complications such as paresthesia in the extremities, weakness, urinary dysfunction, cognitive changes, and gait instability. Prophylactic Vitamin B12 supplementation, at least annually, is recommended by some investigators to mitigate these risks.
Indeed, Glimefest M 1mg/500mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic agents. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available source of glucose, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimefest M 1mg/500mg tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Glimefest M 1mg/500mg Tab...
66
MRP 81
18% off